Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Arash Ghashghai"'
Autor:
Liza Grosman-Rimon, Brian Vadasz, Sarah Hui, Ana C. Alba, Sara Santos, Arash Ghashghai, S. Lalonde, Farid Foroutan, Michael McDonald, Ashley Farrell
Publikováno v:
Heart Failure Reviews. 26:507-519
The benefit of exercise training in cardiac resynchronization therapy (CRT) recipients is not well established. We conducted a systematic review and meta-analysis to determine the effect of exercise training on clinical outcomes in CRT recipients. A
Autor:
Liza, Grosman-Rimon, Sarah, Hui, Sara, Santos, Brian, Vadasz, Farid, Foroutan, Ashley, Farrell, Spencer, Lalonde, Arash, Ghashghai, Michael, McDonald, Ana C, Alba
Publikováno v:
Heart failure reviewsReferences. 26(3)
The benefit of exercise training in cardiac resynchronization therapy (CRT) recipients is not well established. We conducted a systematic review and meta-analysis to determine the effect of exercise training on clinical outcomes in CRT recipients.A c
Autor:
Julieta Lazarte, Arash Ghashghai, Laura C. Tumiati, Stacey Pollock Bar-Ziv, Michael McDonald, Hiroyuki Kawajiri, Vivek Rao, Liza Grosman-Rimon, Ira Jacobs, Avi Fuks, Daniel J. Shogilev, David Z.I. Cherney
Publikováno v:
Canadian Journal of Cardiology. 31:348-356
Background The long-term effects of continuous-flow left ventricular assist device (CF-LVAD) support on trends of inflammatory markers over time are unknown. We examined the hypothesis that the levels of inflammatory markers in CF-LVAD recipients are
Autor:
A.G. Mociornita, Arash Ghashghai, Vivek Rao, Daniel J. Shogilev, Ira Jacobs, Andrzej Chruscinski, Liza Grosman-Rimon, David Z.I. Cherney, Laura C. Tumiati, Michael McDonald, Stacey Pollock Bar-Ziv
Publikováno v:
ASAIO Journal. 60:657-663
Although the newer continuous-flow left ventricular assist devices (CF-LVADs) provide clinical advantages over the pulsatile pumps, the effects of low pulsatility on inflammation are incompletely understood. The objective of our study was to examine
Autor:
David Banner, Giulia Maria Ruggeri, Mitesh V. Badiwala, Massimiliano Meineri, Vivek Rao, Liming Xin, Arash Ghashghai, R. Ribeiro, F. Yu, B. Gellner, J. Alvarez
Publikováno v:
The Journal of Heart and Lung Transplantation. 37:S222
Autor:
Hiroyuki Kawajiri, Arash Ghashghai, Laura Tumiati, Julieta Lazarte, Liza Grosman-Rimon, Vanessa R Luengas, Mitesh Badiwala, Jagdish Butany, Renke Li, Filio Billia, Vivek Rao
Publikováno v:
Circulation. 132
Introduction: Recent studies suggest that ischemia reperfusion injury (IRI) activates the NF-κB pathway leading to the subsequent development of cardiac allograft vasculopathy (CAV). Nrf2 has been suggested to inhibit NF-κB activation during IRI in
Autor:
Liza Grosman-Rimon, Julieta Lazarte, Livia Adams Goldraich, Vivek Rao, Hiroyuki Kawajiri, Arash Ghashghai, Cedric Manlhiot, Diego H. Delgado
Publikováno v:
Circulation. 132
Introduction: Human Leukocyte Antigen (HLA)-G is a natural immune regulator that inhibits T cells, NK cells and B cell activity. In the context of transplantation, less rejection and better graft outcomes are associated with higher serum levels of HL
Autor:
Julieta Lazarte, Livia Goldraich, Cedric Manlhiot, Hiroyuki Kawajiri, Liza Grosman-Rimon, Arash Ghashghai, Vivek Rao, Diego Delgado
Publikováno v:
Circulation. 132
Introduction: Human Leukocyte Antigen (HLA)-G is an immune inhibitor molecule that has been shown to inhibit smooth muscle cell proliferation in vitro and promote vasculature protection against cardiac allograft vasculopathy (CAV). Single polymorphis
Autor:
Roberto Vanin Pinto Ribeiro, Vivek Rao, Hiroyuki Kawajiri, Arash Ghashghai, Mitesh V. Badiwala, David Banner
Publikováno v:
Canadian Journal of Cardiology. 32:S172-S173
Autor:
David Banner, J. Alvarez, Arash Ghashghai, Giulia Maria Ruggeri, Roberto Vanin Pinto Ribeiro, F. Yu, Mitesh V. Badiwala, Vivek Rao, B. Gellner, Massimiliano Meineri, Liming Xin
Publikováno v:
Canadian Journal of Cardiology. 33:S69